These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 1899281)

  • 1. Functional characterization of the developmentally controlled immunoglobulin kappa 3' enhancer: regulation by Id, a repressor of helix-loop-helix transcription factors.
    Pongubala JM; Atchison ML
    Mol Cell Biol; 1991 Feb; 11(2):1040-7. PubMed ID: 1899281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activating transcription factor 1 and cyclic AMP response element modulator can modulate the activity of the immunoglobulin kappa 3' enhancer.
    Pongubala JM; Atchison ML
    J Biol Chem; 1995 Apr; 270(17):10304-13. PubMed ID: 7730336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A developmentally modulated chromatin structure at the mouse immunoglobulin kappa 3' enhancer.
    Roque MC; Smith PA; Blasquez VC
    Mol Cell Biol; 1996 Jun; 16(6):3138-55. PubMed ID: 8649425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site.
    Park K; Atchison ML
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9804-8. PubMed ID: 1946405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YY1 binds to the E3' enhancer and inhibits the expression of the immunoglobulin κ gene via epigenetic modifications.
    Zhou X; Xian W; Zhang J; Zhu Y; Shao X; Han Y; Qi Y; Ding X; Wang X
    Immunology; 2018 Dec; 155(4):491-498. PubMed ID: 30098214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity.
    Pongubala JM; Nagulapalli S; Klemsz MJ; McKercher SR; Maki RA; Atchison ML
    Mol Cell Biol; 1992 Jan; 12(1):368-78. PubMed ID: 1729611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of the 3'-enhancer region in immunoglobulin kappa gene expression.
    Meyer KB; Sharpe MJ; Surani MA; Neuberger MS
    Nucleic Acids Res; 1990 Oct; 18(19):5609-15. PubMed ID: 2120679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-range interactions between three transcriptional enhancers, active Vkappa gene promoters, and a 3' boundary sequence spanning 46 kilobases.
    Liu Z; Garrard WT
    Mol Cell Biol; 2005 Apr; 25(8):3220-31. PubMed ID: 15798207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFN-gamma induces the kappa intron enhancer via an IFN-stimulated response element.
    Damore MA; Omori SA; Wall R
    J Immunol; 1996 Apr; 156(7):2451-7. PubMed ID: 8786304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Igκ gene enhancers, E3' and Ed, are essential for triggering transcription.
    Zhou X; Xiang Y; Garrard WT
    J Immunol; 2010 Dec; 185(12):7544-52. PubMed ID: 21076060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 3' enhancer region determines the B/T specificity and pro-B/pre-B specificity of immunoglobulin V kappa-J kappa joining.
    Hiramatsu R; Akagi K; Matsuoka M; Sakumi K; Nakamura H; Kingsbury L; David C; Hardy RR; Yamamura K; Sakano H
    Cell; 1995 Dec; 83(7):1113-23. PubMed ID: 8548799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunoglobulin kappa locus contains a second, stronger B-cell-specific enhancer which is located downstream of the constant region.
    Meyer KB; Neuberger MS
    EMBO J; 1989 Jul; 8(7):1959-64. PubMed ID: 2507312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ig kappa 3'-enhancer triggers gene expression in early B lymphocytes but its activity is enhanced on B cell activation.
    Meyer KB; Teh YM; Neuberger MS
    Int Immunol; 1996 Oct; 8(10):1561-8. PubMed ID: 8921435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementation between two cell lines lacking kappa enhancer activity: implications for the developmental control of immunoglobulin transcription.
    Atchison ML; Perry RP
    EMBO J; 1988 Dec; 7(13):4213-20. PubMed ID: 2854057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of an octamer-binding site in the mouse kappa light-chain immunoglobulin enhancer.
    Currie RA; Roeder RG
    Mol Cell Biol; 1989 Oct; 9(10):4239-47. PubMed ID: 2511430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental regulation of the kappa locus involves both positive and negative sequence elements in the 3' enhancer that affect synergy with the intron enhancer.
    Liu X; Prabhu A; Van Ness B
    J Biol Chem; 1999 Feb; 274(6):3285-93. PubMed ID: 9920868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinant differences between the rabbit and mouse immunoglobulin kappa enhancers impair the activity of the rabbit enhancer in mouse myeloma cells.
    Akimenko MA; Ekker M; Doyen N; Biben C; Rougeon F
    Nucleic Acids Res; 1989 Jun; 17(12):4745-55. PubMed ID: 2501761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organization of the transcription factor binding sites in the kappa Ig intron enhancer. Effects of position, orientation, and spacing.
    Schanke JT; Van Ness BG
    J Immunol; 1994 Nov; 153(10):4565-72. PubMed ID: 7963528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel enhancer in the immunoglobulin lambda locus is duplicated and functionally independent of NF kappa B.
    Hagman J; Rudin CM; Haasch D; Chaplin D; Storb U
    Genes Dev; 1990 Jun; 4(6):978-92. PubMed ID: 2116989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer.
    Hodawadekar S; Park K; Farrar MA; Atchison ML
    J Immunol; 2012 Mar; 188(5):2276-84. PubMed ID: 22279106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.